Speaker Detail

Jonathan Leff is a managing director with Warburg Pincus, where he has been a member of the HealthCare Group since 1996. Leff is responsible for the firm's investment efforts in biotechnology. Currently he is a director of Allos Therapeutics, InterMune, ReSearch Pharmaceutical Services, Sophiris Bio, Rib-X Pharmaceuticals and Talon Therapeutics. In addition, he serves on the Executive Committee of the board of the National Venture Capital Association and leads the NVCA's life sciences industry efforts as chairman of its Medical Innovation and Competitiveness Coalition. Leff is a board member of the Biotechnology Industry Organization as well as Friends of Cancer Research and the Spinal Muscular Atrophy Foundation. He also sits on the Board of Visitors of Columbia University Medical Center. Leff received an A.B. degree from Harvard University and an M.B.A. from Stanford University.